Learn the Latest for High-Risk Breast Cancer Patients Register Today

News

You can view the latest news, articles and announcements on EndoPredict below or visit our official Eurobio Scientific News page.

endopredict-at-sabcs-prospective-long-term-and-real-world-data Thumbnail

EndoPredict® at SABCS – Prospective long-term and real-world data

 December 16, 2022

Two prospective real-world studies presented at SABCS show EndoPredict® accurately guides decisions on chemotherapy in ER+, HER2- breast cancer 12th Decemb...

watch-myriad-genetics-esmo-2022-industry-satellite-symposium Thumbnail

Watch Myriad Genetics' ESMO 2022 Industry Satellite Symposium

 September 19, 2022

Should we use genetic signatures for chemotherapy decisions in ER+/HER2- premenopausal patients? Dr. Anastasia Constantinidou shares key new data from ESMO Con...

endopredict-informs-treatment-decisions-for-premenopausal-breast-cancer Thumbnail

EndoPredict informs treatment decisions for premenopausal breast cancer

 August 31, 2022

New publication shows EndoPredict Breast Cancer Prognostic Test accurately identified premenopausal women with ER+, HER2- breast cancer who could safely avoid ...

high-adherence-to-endopredict-test-results-in-extended-endocrine-therapy-decision-making-in-early-breast-cancer Thumbnail

High adherence to EndoPredict test results in extended endocrine therapy decision making in early breast cancer

 June 9, 2022

Clinicians demonstrated up to 100% adherence to EndoPredict test results in extended endocrine therapy decision making As a leader in genetic testing and ...